General Information of Drug Transporter (DT)
DT ID DTD0433 Transporter Info
Gene Name SLC62A1
Transporter Name Progressive ankylosis protein homolog
Gene ID
56172
UniProt ID
Q9HCJ1
Post-Translational Modification of This DT
Overview of SLC62A1 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X-Ubiquitination X: Amino Acid

Phosphorylation

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC62A1 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

67

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC62A1 Serine 67 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC62A1 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

79

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC62A1 Serine 79 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC62A1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

470

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC62A1 Serine 470 has the potential to affect its expression or activity.

  Threonine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC62A1 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

315

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC62A1 Threonine 315 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC62A1 [4] , [5]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

300

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC62A1 Tyrosine 300 has the potential to affect its expression or activity.

Ubiquitination

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC62A1 [4] , [6]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

186

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC62A1 Cystine 186 has the potential to affect its expression or activity.

  Lysine

          6 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC62A1 [4] , [6]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

42

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC62A1 Lysine 42 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC62A1 [4] , [6]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

70

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC62A1 Lysine 70 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC62A1 [4] , [7]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

80

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC62A1 Lysine 80 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC62A1 [4]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

85

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC62A1 Lysine 85 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC62A1 [4] , [6]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

127

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC62A1 Lysine 127 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC62A1 [4] , [6]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

214

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC62A1 Lysine 214 has the potential to affect its expression or activity.

  Serine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC62A1 [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

57

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC62A1 Serine 57 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC62A1 [4] , [7]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

52

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC62A1 Tyrosine 52 has the potential to affect its expression or activity.

  Valine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC62A1 [4] , [6]

Role of PTM

Potential impacts

Modified Residue

Valine

Modified Location

99

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC62A1 Valine 99 has the potential to affect its expression or activity.
References
1 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
2 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: ANKH_HUMAN)
3 Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Mol Biosyst. 2013 Apr 5;9(4):732-49.
4 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
5 Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007 Dec 14;131(6):1190-203.
6 Global identification of modular cullin-RING ligase substrates. Cell. 2011 Oct 14;147(2):459-74.
7 Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes. Cell Syst. 2016 Oct 26;3(4):395-403.e4.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.